Clinical Services International
Orchestrating Success in Clinical Trials Supply

The timely availability of essential medicines and ancillaries is essential for clinical trial success. Without these critical components, even well-recruited trials fail. An industry leader in the clinical trial supply domain, Clinical Services International (CSI) has a proven track record of ensuring seamless trial operations and patient care.

Highlighting the company’s pivotal role in the drug development and clinical trial domains, Dr. Vanessa Dekou, Managing Director at CSI, says, “We make sure that every patient receives the required dosage upon their arrival at the trial site, which ensures the drug development cycle progresses in a timely manner.”

Its diverse clientele includes top 10 pharmaceutical and blue-chip biotech firms, clinical research organizations (CRO) and contract development and manufacturing organizations (CDMOs) that value its extensive global network and ability to source medicines from around the world. Over the last decade, CSI has supported over 1000 studies globally, maintaining an impeccable record of 100% on-time deliveries.

Navigating the complexities of clinical trial supply, the company acquires a diverse range of best-selling medicines. Its direct accounts with pharmaceutical companies facilitate the timely procurement of branded and generic drugs. At the same time, the company's scientific expertise and regulatory knowledge guarantee compliance and efficient international product movement. This reliability and its vast scientific acumen distinguish CSI as a trusted partner in the global drug development sector.

Empowered by its team’s multi-disciplinary scientific backgrounds and experience in drug development and partner warehouses worldwide, CSI has successfully supported trials across 60 countries. This global reach enables CSI to meet and exceed client expectations worldwide. Equally impressive is its capital market and financial understanding and proficiency in extracting strategic insights, which drive effective communication with client C-suites.

Rooted in strong project management, the company's services include protocol analysis, budgeting, sourcing, supply management and regulatory compliance. Once all relevant stakeholders agree upon a strategy, it moves to the execution phase, which comprises procuring medicines as well as managing storage and distribution while maintaining compliance.

A notable example of CSI’s expertise and experience is when a large, listed biotech company approached CSI for their phase 3 trial which involved several expensive oncology products and spanned 17 countries. The client was in jeopardy due to their previous supplier failing to procure and distribute the requirements on time. CSI capitalized on its extensive relationships with manufacturers and devised a hybrid sourcing solution to tackle this challenge.

CSI leveraged all the relationships we have with the manufacturers, and worked closely with the client, performing a hybrid sourcing solution, procuring products locally for some countries and centrally for the majority.

This strategy allowed CSI to bring the study back on track within three months and ensure the biotech company could run it smoothly thereafter. The timely execution of the study led to a surge in the client’s share price (over 40%), ultimately leading to their acquisition by a top pharmaceutical company for €3 billion. Above all, CSI’s intervention not only rescued the study but significantly enhanced shareholder value for the client.

Beyond its success in the clinical trial supply sector, CSI is known for its commitment to sustainability. A testament to this is its recent recognition as a Platinum-rated company by EcoVadis, a prestigious sustainability assessment organization.

This dedication to sustainability is matched by CSI's forward-thinking approach and expertise. Supported by significant research software investments, CSI offers innovative solutions backed by comprehensive databases which enable proactive client support.